Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference35 articles.
1. International trends in colorectal cancer incidence rates;Center;Cancer Epidemiol Biomarkers Prev,2009
2. Adaptation of international guidelines for metastatic colorectal cancer: an Asian consensus;Cheng;Clin Colorectal Cancer,2014
3. Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012;Ku;Lancet Oncol,2012
4. Trends in colorectal cancer in the south of the Netherlands 1975–2007: rectal cancer survival levels with colon cancer survival;Lemmens;Acta Oncol,2010
5. Improving outcomes in colorectal cancer: where do we go from here?;Van Cutsem;Eur J Cancer,2013
Cited by 555 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation;European Journal of Cancer;2024-03
2. Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study;Cancer Management and Research;2024-02
3. Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer;Cells;2024-01-28
4. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer;BMC Cancer;2024-01-02
5. Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China;BMC Cancer;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3